HOME Research Insight Strategies Included in Needle Free Injection Systems Market are Agreements, Collaboration, Contracts, Expansion, Product Upgrades, Approvals and Partnerships



Strategies Included in Needle Free Injection Systems Market are Agreements, Collaboration, Contracts, Expansion, Product Upgrades, Approvals and Partnerships


Key Players in the needle-free injection system Market Pursue Agreements, Collaboration Expansion, Product Upgrades, Partnerships, and Others (Approvals and Certifications) as their Key Growth Strategies

Prominent players in the needle-free injection system Market include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).

Other players in the market include Akra Dermojet (France), Eternity Healthcare, Inc. (U.S.), Portal Instruments (U.S.), Shreya Life Sciences Private Limited (India), Lundbeck (Denmark), Biovalve Technologies (U.S.), D Antonio Consultants International, Inc. (U.S.), EMD Serono, Inc. (U.S.).

Companies are focusing on adopting organic as well as inorganic growth strategies such as acquisition, agreements, collaboration, expansion, product upgrades, partnerships, and others (approvals and certifications) to synergistically offer advanced needle-free injection solutions in the market. These strategies help market players to strengthen their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

The overall growth strategies mapped from 2013 to 2016 include agreements, collaboration, contracts, expansion, product upgrades, approvals, and partnerships. The agreement, collaboration and partnership accounted for the largest share of the overall growth strategies mapped in the above mentioned period. Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Crossject SA (France) is the companies that majorly adopted this strategy.

Some of the strategies adopted by major players are in August 2016, PharmaJet and World Health Organization (U.S.) under the terms of this agreement, PharmaJet will provide its needle-free technology to be used in the global effort to eradicate polio. Furthermore, In march 2015, Antares Pharma announced that its partner Ferring Pharmaceuticals Inc. (Switzerland) received FDA approval for the name change of its recently acquired recombinant human growth hormone to be marketed in the U.S. as ZOMACTON (somatropin [rDNA origin]) and the needle-free delivery system to be marketed in the U.S. as ZOMA-Jet. Moreover, in October 2015 PharmaJet partnered with four U.S.-based distributors, namely, ABO Pharmaceuticals, FFF Enterprises, McKesson Corporation, and Moore Medical. This partnership will help the company to offer the PharmaJet Needle-Free Injection System for needle-free flu shots across the U.S. adoption of such strategies boosting the market growth.

Related Reports:

Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021

Contact:
Mr. Rohan
Markets and Markets 
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

 

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports